humulene and Hepatitis-B

Topics: Cannabis; Hepatitis B; Humans; Saliva; Substance-Related Disorders

The sharp rise in drug abuse in the past decade has led to the development of new sources of information on drug-abuse trends. These include surveys, drug-related emergencies, drug-abuse treatment, hepatitis rates, and various types of law enforcement information. This paper summarizes data currently available for heroin, marijuana, cocaine, amphetamines, and barbiturates. Heroin use occurred in epidemic form in the late 1960s. Some cities, which had experienced a subsequent decline in heroin use, recently have reported an increase again. Marijuana use has increased steadily. The abuse of amphetamines and barbiturates appears to be growing. Trends on cocaine use are unclear. The development of ongoing, quantitative data-collection systems is beginning to clarify many of the issues regarding drug-use patterns and trends. With the possible exception of survey data, however, each indicator provides data only on selected segments of the drug-using population.

Topics: Amphetamines; Barbiturates; Cannabis; Disease Outbreaks; Hepatitis B; Heroin; Humans; Narcotics; Substance-Related Disorders; United States

Beginning in 1971, acute viral hepatitis was epidemic among US soldiers stationed in Europe, with a total of over 8,700 cases reported between 1971 and 1974. Hepatitis B surface antigen (HBsAg) determinations suggest a predominance of hepatitis B. In the Nuremberg area, primary association was with the illicit use of drugs. This association was demonstrated by a chronologic relationship between measurable community drug use and the number of hepatitis admissions three to six months later and by a case-control study. Parenteral drug use and, to a lesser degree, cannabis smoking appeared to be factors in disease transmission. Sharing of illicit drugs with a hepatitis contact, whether parenterally or orally, was associated with increased risk of contracting the disease.

Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Cannabis; Disease Outbreaks; Female; Germany, West; Hepatitis B; Hepatitis B Antigens; Humans; Injections; Male; Military Medicine; Phytotherapy; Substance-Related Disorders; United States

Topics: Acute Kidney Injury; Administration, Oral; Adolescent; Alkaline Phosphatase; Amenorrhea; Amphetamine; Barbiturates; Cannabis; Child; Cocaine; Eosinophilia; False Positive Reactions; Female; Hepatic Encephalopathy; Hepatitis B; Heroin; Humans; Injections, Intravenous; Injections, Subcutaneous; Juvenile Delinquency; Lysergic Acid Diethylamide; Peptic Ulcer; Pneumonia; Pseudotumor Cerebri; Substance Withdrawal Syndrome; Substance-Related Disorders

Topics: Adolescent; Adult; Alcoholism; Amphetamine; Barbiturates; Cannabis; Cocaine; Hepatitis A; Hepatitis B; Heroin; Humans; Lysergic Acid Diethylamide; Male; Middle Aged; Opium; Phenothiazines; Prisons; Psychotic Disorders; Sepsis; Smoking; Substance-Related Disorders; United Kingdom

Topics: Adolescent; Adult; Cannabis; Female; Hallucinogens; Hepatitis B; Humans; Injections, Intravenous; Lysergic Acid Diethylamide; Male; Substance-Related Disorders

Topics: Adult; Cannabis; Hepatitis B; Humans; Injections, Intravenous; Male; Methylphenidate; Opium; Phenmetrazine; Substance-Related Disorders; Tattooing

Topics: Adolescent; Adult; Cannabis; Hepatitis B; Humans; Injections, Intravenous; Lysergic Acid Diethylamide; Male; Opium; Phytotherapy; Substance-Related Disorders